Germany
Japan
United Kingdom
China
USD 509.00
2 Weeks
Antibodies
View as table Download
USD 509.00
2 Weeks
USD 509.00
2 Weeks
USD 509.00
2 Weeks
Rabbit Polyclonal Antibody against BRAF (Center)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human (Predicted: Mouse, Chicken) |
| Conjugation | Unconjugated |
| Immunogen | This B-RAF antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 424-453 amino acids from the Central region of human B-RAF. |
Rabbit polyclonal B-RAF (Phospho-Ser446) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human B-RAF around the phosphorylation site of serine 446 (R-D-SP-S-D). |
| Modifications | Phospho-specific |
Rabbit polyclonal B-RAF (Ab-446) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human B-RAF around the phosphorylation site of serine 446 (R-D-SP-S-D). |
Active filters
Category
-
Antibodies
- Primary Antibodies
Target Symbol
- B RAF
Reactivities
- Mouse
Applications
- WB
Families
- Protein Kinase
Filter by
Antibody Hosts
Isotypes
Clonalities
Conjugates
Carrier-free
Knockout (KO) Validation
Modifications
Assay Types
Pathways
- Acute myeloid leukemia (90)
- Bladder cancer (90)
- Chemokine signaling pathway (90)
- Chronic myeloid leukemia (90)
- Colorectal cancer (90)
- Endometrial cancer (90)
- ErbB signaling pathway (90)
- Focal adhesion (90)
- Glioma (90)
- Insulin signaling pathway (90)
- Long-term depression (90)
- Long-term potentiation (90)
- MAPK signaling pathway (90)
- Melanoma (90)
- Natural killer cell mediated cytotoxicity (90)
- Neurotrophin signaling pathway (90)
- Non-small cell lung cancer (90)
- Pancreatic cancer (90)
- Pathways in cancer (90)
- Progesterone-mediated oocyte maturation (90)
- Prostate cancer (90)
- Regulation of actin cytoskeleton (90)
- Renal cell carcinoma (90)
- Thyroid cancer (90)
- Vascular smooth muscle contraction (90)
- mTOR signaling pathway (90)